Growth Metrics

Ptc Therapeutics (PTCT) Amortizatization of Intangibles: 2014-2025

Historic Amortizatization of Intangibles for Ptc Therapeutics (PTCT) over the last 12 years, with Sep 2025 value amounting to $6.1 million.

  • Ptc Therapeutics' Amortizatization of Intangibles rose 106.60% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.6 million, marking a year-over-year increase of 33.88%. This contributed to the annual value of $12.5 million for FY2024, which is 27.50% up from last year.
  • As of Q3 2025, Ptc Therapeutics' Amortizatization of Intangibles stood at $6.1 million, which was up 33.96% from $4.6 million recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Amortizatization of Intangibles high stood at $6.1 million for Q3 2025, and its period low was $1.7 million during Q4 2023.
  • For the 3-year period, Ptc Therapeutics' Amortizatization of Intangibles averaged around $3.2 million, with its median value being $2.9 million (2023).
  • Data for Ptc Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 988.24% (in 2021) and a maximum YoY decrease of 95.37% (in 2021) over the last 5 years.
  • Over the past 5 years, Ptc Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $1.9 million in 2021, then increased by 27.22% to $2.4 million in 2022, then decreased by 29.76% to $1.7 million in 2023, then surged by 54.52% to $2.6 million in 2024, then skyrocketed by 106.60% to $6.1 million in 2025.
  • Its Amortizatization of Intangibles stands at $6.1 million for Q3 2025, versus $4.6 million for Q2 2025 and $2.3 million for Q1 2025.